Navigation Links
US Oncology Launches Oncology-Specific Billing and Reimbursement Service
Date:6/4/2008

Oncology Reimbursement Solutions provides revenue cycle management expertise designed to improve oncology practice financial performance

HOUSTON, June 4 /PRNewswire/ -- US Oncology, Inc. is launching Oncology Reimbursement Solutions (ORS), an oncology-focused billing and reimbursement service designed to increase operational efficiency and improve the economics of independent community-based oncology practices.

With a focus on maximizing key reimbursement metrics, ORS offers a comprehensive revenue cycle management program, a full curriculum of oncology billing and coding education, and assistance in accessing patient assistance programs.

The stand-alone service provides oncologists with unparalleled expertise in revenue cycle management to ensure proper reimbursement for their services. As a leader in oncology business operations, US Oncology has an experienced reimbursement team that supports the billing processes for over 1,000 oncology providers in more than 325 sites of service across the nation. The US Oncology reimbursement team oversees approximately $8 billion in gross patient revenue each year. ORS leverages this vast experience to offer services that support all critical front and back office activities of a practice.

"In today's complex and evolving oncology reimbursement landscape, oncologists require a comprehensive revenue cycle management solution designed specifically for their practices," said Karen Pilley, vice president of Reimbursement Solutions for US Oncology. "ORS expertly meets that need by providing support through proven operational processes, state-of-the-art technology, and US Oncology's unparalleled oncology reimbursement expertise."

US Oncology has customized the ORS practice management system to specifically meet the complex needs of oncologists. Understanding the need for an integrated revenue cycle model, the ORS technology solution supports both front and back office business functions. Benefits of the technology include efficient scheduling models; integrated claim scrubbing; payer contract management; a virtually paperless accounts receivable and denial management process; and advanced reporting and analytics.

Payer contract management helps ensure accurate and timely payments through monitoring of contractual rates and fee schedules. Under the ORS model, overpayments or underpayments are identified at the time of cash posting. Proper contract management helps practices reduce write-offs of collectible revenue and apply EOB audit processes on all new and existing contracts.

Proper denial management is critical in creating an efficient revenue cycle process. The ORS team identifies the source of any issues and determines a recommended plan of action. Whether working with the practice to put proper front office procedures in place or working complex denials with payers, ORS aims to resolve the source of the denial.

"The goal of ORS is to make sure we resolve the reasons claims are denied in the first place," said Karen Pilley. "With our advanced technology solution, we have the ability to write claim edits and increase our claim scrubber functionality. This means the claims have a greater likelihood of being approved the first time they are submitted."

ORS also offers valuable billing and coding education for practice staff. Resources include a web-based library featuring articles on coding updates and reimbursement operational best practices; audio conference and webcast education; billing, coding and E/M educational tutorials; and a field team available for state-specific reimbursement needs.

Another service feature is the ORS Patient Assistance Support team. This team works with national foundations to help secure funding for financially qualified patients who cannot afford their coinsurance for oncology treatments. They help patients navigate the national assistance programs available to them, providing support in the application, follow-up and processing steps. By acting as an extension of the practices, ORS Patient Assistance Support also works with drug manufacturers to help patients without insurance obtain oncology drugs at no cost or very low cost. At the request of practices affiliated with US Oncology, the experienced ORS Patient Assistance Support team secured over $14 million in funding in 2007 for cancer patients in need.

About US Oncology, Inc.

US Oncology, headquartered in Houston, works closely with physicians, manufacturers and payers to identify and deliver innovative services that enhance patient access to advanced cancer care. US Oncology supports one of the nation's foremost cancer treatment and research networks accelerating the availability and use of evidence-based medicine and shared best practices.

US Oncology's expertise in supporting every aspect of the cancer care delivery system -- from drug development to treatment and outcomes measurement, enables the company to help increase the efficiency and safety of cancer care. According to the company's last quarterly earnings report, US Oncology is affiliated with 1,247 physicians operating in 472 locations, including 91 radiation oncology facilities in 39 states. For more information, visit the company's Web site, http://www.usoncology.com.


'/>"/>
SOURCE US Oncology, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Isis Partners Present Clinical Data on Antisense Drugs at the American Society of Clinical Oncology
2. Society for Translational Oncology Launches Updated Website
3. BUMC provost, BUSM dean, to be honored at worlds largest meeting of oncology professionals
4. Varian Medical Systems to Develop Interface Between the ARIA(TM) Oncology Information System and the Monarch250(TM) Proton Radiotherapy System From Still River Systems
5. IDM Pharma Announces Presentations at 44th American Society of Clinical Oncology Annual Meeting
6. Abbott to Present Data on Novel Cancer Treatments at American Society of Clinical Oncology Annual Meeting
7. US Oncology Reports First Quarter 2008 Results
8. ACT Biotech Acquires Clinical and Early Stage Oncology Portfolio Licenses From Bayer Healthcare
9. Texas Oncology Reminds Women Youre the Best, Get the Tests
10. US Oncology Applauds Journal of Clinical Oncology Study Highlighting Value of PET Scans for Cancer Patients With Various Types of Malignancies
11. Lilly Oncology to Unveil More Than 50 Studies at ASCO 2008
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/24/2017)... ... , ... With ProGlass Prism users now have the ability to simulate prism ... position, rotation, distortion, edge softness, edge blur, chromatic aberration, individual glass position offset, anchor ... Prism users are given the tools and effects to generate a fractal prismatic ...
(Date:2/24/2017)... ... ... Indiana Fiber Network (IFN) President and CEO Kelly C. Dyer recently announced that he ... of the Management Committee when IFN was originally formed in 2002 where he was ... development of the business plan. He became the first paid employee of IFN ...
(Date:2/24/2017)... ... 24, 2017 , ... Castle Farms, the celebrated Northern ... with the winning couple announced on Feb. 14, 2017, on Facebook. The free ... vendors: A Matter of Taste, Ryan Rousseau Enterprises, A Touch of Spring and ...
(Date:2/23/2017)... ... 2017 , ... The Lymphoma Research Foundation (LRF) – the ... the lymphoma community through a comprehensive series of education programs, outreach initiatives and ... Beach to host its Swirl: Miami Wine Tasting Event on March 28, 2017. ...
(Date:2/23/2017)... ... 2017 , ... Hamlin Dental Group and Dr. Hamid Reza, dentist in ... the month of February, patients who visit Hamlin Dental Group will receive a ticket ... two at the Cheesecake Factory. , Tickets are available for routine dental visits ...
Breaking Medicine News(10 mins):
(Date:2/24/2017)... Research and Markets has announced the addition ... 2016" report to their offering. ... The latest research Urinary Incontinence Drugs Price ... in the global Urinary Incontinence market. The research answers the ... drugs marketed for Urinary Incontinence and their clinical attributes? How are ...
(Date:2/23/2017)... Research and Markets has announced the addition ... - 2016" report to their offering. ... The latest research Autism Spectrum Disorder ... and benchmarks in the global Autism Spectrum Disorder market. The ... are the key drugs marketed for Autism Spectrum Disorder and their ...
(Date:2/23/2017)... , Südkorea, 23. Februar 2017 LG ... für Sterilisationsaufgaben vorgestellt. Die Sterilisationsleistung beträgt das 1,5-fache des ... ultraviolette Strahlung im Bereich zwischen 200 und 280 nm und ... von Bakterien, indem es ihre DNA zerstört. Das Produkt ... ...
Breaking Medicine Technology: